Literature DB >> 26366404

Sixty shades of oxygen-an attractive opportunity for cancer immunotherapy.

Amr Hasan1, Massimiliano Mazzone1.   

Abstract

Entities:  

Year:  2015        PMID: 26366404      PMCID: PMC4543336          DOI: 10.3978/j.issn.2305-5839.2015.07.25

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  15 in total

1.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

2.  Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.

Authors:  Andrea Casazza; Damya Laoui; Mathias Wenes; Sabrina Rizzolio; Nicklas Bassani; Marco Mambretti; Sofie Deschoemaeker; Jo A Van Ginderachter; Luca Tamagnone; Massimiliano Mazzone
Journal:  Cancer Cell       Date:  2013-12-09       Impact factor: 31.743

Review 3.  Targeting hypoxia in cancer therapy.

Authors:  William R Wilson; Michael P Hay
Journal:  Nat Rev Cancer       Date:  2011-06       Impact factor: 60.716

4.  Gene-targeting of Phd2 improves tumor response to chemotherapy and prevents side-toxicity.

Authors:  Rodrigo Leite de Oliveira; Sofie Deschoemaeker; Anne-Theres Henze; Koen Debackere; Veronica Finisguerra; Yukiji Takeda; Carmen Roncal; Daniela Dettori; Evelyne Tack; Yannick Jönsson; Lorenzo Veschini; Annelies Peeters; Andrey Anisimov; Matthias Hofmann; Kari Alitalo; Myriam Baes; Jan D'hooge; Peter Carmeliet; Massimiliano Mazzone
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

5.  Immunological mechanisms of the antitumor effects of supplemental oxygenation.

Authors:  Stephen M Hatfield; Jorgen Kjaergaard; Dmitriy Lukashev; Taylor H Schreiber; Bryan Belikoff; Robert Abbott; Shalini Sethumadhavan; Phaethon Philbrook; Kami Ko; Ryan Cannici; Molly Thayer; Scott Rodig; Jeffrey L Kutok; Edwin K Jackson; Barry Karger; Eckhard R Podack; Akio Ohta; Michail V Sitkovsky
Journal:  Sci Transl Med       Date:  2015-03-04       Impact factor: 17.956

6.  HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF.

Authors:  Charlotte Rolny; Massimiliano Mazzone; Sònia Tugues; Damya Laoui; Irja Johansson; Cathy Coulon; Mario Leonardo Squadrito; Inmaculada Segura; Xiujuan Li; Ellen Knevels; Sandra Costa; Stefan Vinckier; Tom Dresselaer; Peter Åkerud; Maria De Mol; Henriikka Salomäki; Mia Phillipson; Sabine Wyns; Erik Larsson; Ian Buysschaert; Johan Botling; Uwe Himmelreich; Jo A Van Ginderachter; Michele De Palma; Mieke Dewerchin; Lena Claesson-Welsh; Peter Carmeliet
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

7.  The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.

Authors:  Franca Piras; Romano Colombari; Luigi Minerba; Daniela Murtas; Carlo Floris; Cristina Maxia; Arianna Corbu; M Teresa Perra; Paola Sirigu
Journal:  Cancer       Date:  2005-09-15       Impact factor: 6.860

8.  Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.

Authors:  Massimiliano Mazzone; Daniela Dettori; Rodrigo Leite de Oliveira; Sonja Loges; Thomas Schmidt; Bart Jonckx; Ya-Min Tian; Anthony A Lanahan; Patrick Pollard; Carmen Ruiz de Almodovar; Frederik De Smet; Stefan Vinckier; Julián Aragonés; Koen Debackere; Aernout Luttun; Sabine Wyns; Benedicte Jordan; Alberto Pisacane; Bernard Gallez; Maria Grazia Lampugnani; Elisabetta Dejana; Michael Simons; Peter Ratcliffe; Patrick Maxwell; Peter Carmeliet
Journal:  Cell       Date:  2009-02-12       Impact factor: 41.582

9.  Vascular normalization in Rgs5-deficient tumours promotes immune destruction.

Authors:  Juliana Hamzah; Manfred Jugold; Fabian Kiessling; Paul Rigby; Mitali Manzur; Hugo H Marti; Tamer Rabie; Sylvia Kaden; Hermann-Josef Gröne; Günter J Hämmerling; Bernd Arnold; Ruth Ganss
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

Review 10.  Targeting the tumor vasculature to enhance T cell activity.

Authors:  Evripidis Lanitis; Melita Irving; George Coukos
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

View more
  2 in total

Review 1.  Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis.

Authors:  Massimiliano Mazzone; Gabriele Bergers
Journal:  Annu Rev Physiol       Date:  2019-02-10       Impact factor: 19.318

Review 2.  Advancing Clostridia to Clinical Trial: Past Lessons and Recent Progress.

Authors:  Alexandra M Mowday; Christopher P Guise; David F Ackerley; Nigel P Minton; Philippe Lambin; Ludwig J Dubois; Jan Theys; Jeff B Smaill; Adam V Patterson
Journal:  Cancers (Basel)       Date:  2016-06-28       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.